Home › Funds › Defilade Capital Management, L.P. › ENOV

Defilade Capital Management, L.P. position in ENOV

ENOVIS CORPORATION · Health Care

Defilade Capital Management, L.P. reported holding 531,945 shares of ENOV (ENOVIS CORPORATION) in its Q2 2026 13F filing — a position valued at US$11.0M, representing 1.47% of its reported portfolio and ranking #29 among its reported holdings. Defilade Capital Management, L.P. first reported this position in Q2 2026.

Latest position (Q2 2026)531.95K sh
Reported value held$11.01M
Portfolio Weight1.47%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s ENOV position evolved

Defilade Capital Management, L.P. first disclosed a stake in ENOV in Q2 2026 at 531,945 shares (US$11.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 531.95K $11.01M New

About ENOV and 13F data

ENOV (ENOVIS CORPORATION) is a Health Care company. 19 other funds we track also report a position in ENOV — the largest reported positions include Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PARADIGM CAPITAL MANAGEMENT INC/NY (US$28.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENOV

All ENOV fund holders →

FAQ

How long has Defilade Capital Management, L.P. held ENOV?

Defilade Capital Management, L.P. has disclosed ENOV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Defilade Capital Management, L.P.'s current position in ENOV?

As of Q2 2026, Defilade Capital Management, L.P. holds 531.95K shares of ENOV (ENOVIS CORPORATION), valued at $11.01M, representing 1.47% of its reported portfolio and ranking #29.

Has Defilade Capital Management, L.P. been buying or selling ENOV?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in ENOV.

Which other funds hold ENOV?

Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PARADIGM CAPITAL MANAGEMENT INC/NY, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.